ArticleFrontiers in cardiovascular medicine2025
A case report of pneumopericardium secondary to suspected bronchopericardial fistula post lung resection: diagnosis and management guided by transthoracic echocardiography.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pneumopericardium is a rare, life-threatening condition characterized by abnormal gas accumulation in the pericardial cavity, most commonly secondary to trauma, surgical procedures, or fistulous communications with adjacent hollow organs. We report a 59-year-old male patient who presented with chest pain. Initial transthoracic echocardiography (TTE) only detected minimal pericardial effusion, failing to identify pneumopericardium. Subsequent serial TTE monitoring progressively revealed pathognomonic signs of pneumopericardium, including microbubble swirl, air gap artifact, and a definitive fluid-gas level. Notably, the microbubble swirl sign is a typical marker for the early diagnosis of pneumopericardium, and its presence should raise an immediate suspicion of this condition. The diagnosis was ultimately confirmed, and computed tomography (CT) was further performed to corroborate these echocardiographic findings. Therapeutically, ultrasound-guided pericardiocentesis was successfully conducted to drain the pericardial gas. However, post-procedural recurrent pneumopericardium occurred, prompting suspicion of an underlying persistent fistula, specifically a bronchopericardial fistula. Despite aggressive clinical interventions, the patient ultimately succumbed to the disease following voluntary withdrawal of care. This case highlights three key clinical implications: (1) Serial TTE monitoring is of critical value in the dynamic diagnosis of pneumopericardium, particularly when initial imaging yields non-diagnostic results; (2) TTE serves as a dual utility tool-guiding emergent therapeutic interventions (e.g., ultrasound-guided pericardiocentesis) and facilitating etiological investigation (e.g., identifying fistula-related gas recurrence); (3) Clinicians should maintain heightened vigilance for underlying pathological causes (e.g., bronchopericardial fistula) in patients with recurrent pneumopericardium to optimize treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.